Cramer: The lucrative journey of Allergan By: CNBC.com News November 17, 2014 at 18:07 PM EST Jim Cramer reviews the acquisition of Allergan by Actavis to judge just how lucrative the deal could really be for shareholders. Read More >> Related Stocks: Actavis Plc Alibaba Group Holding Ltd Gameplan Inc Valeant Pharmaceuticals International, Inc.